4-{[(E)-2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethenyl]amino}-N,N-dimethylbenzene-1-sulfonamide

Catalog No. :
ACLKRH682
CAS No. :
303997-75-3
Molecular Formula :
C16H15ClF3N3O2S
Molecular Weight :
405.83

IUPAC Name:(E)-4-((2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)vinyl)amino)-N,N-dimethylbenzenesulfonamide

4-{[(E)-2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethenyl]amino}-N,N-dimethylbenzene-1-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-{[(E)-2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethenyl]amino}-N,N-dimethylbenzene-1-sulfonamide
IUPAC Name(E)-4-((2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)vinyl)amino)-N,N-dimethylbenzenesulfonamide
Molecular FormulaC16H15ClF3N3O2S
Molecular Weight405.83
SMILESO=S(C1=CC=C(N/C=C/C2=NC=C(C(F)(F)F)C=C2Cl)C=C1)(N(C)C)=O
InChI KeyHXNZDCCHGBBTEP-BQYQJAHWSA-N
Synonym4-((2-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]VINYL)AMINO)-N,N-DIMETHYLBENZENESULFONAMIDE;4-{[(E)-2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethenyl]amino}-N,N-dimethylbenzene-1-sulfonamide;Benzenesulfonamide, 4-[[2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]ethenyl]amino]-N,N-dimethyl-
CAS No.303997-75-3

Synthetic Route by SureRoute

1. ACLKRH682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLKRH682 route product structure diagram
    ACLKRH682303997-75-3
Inquiry

2. ACLKRH682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLKRH682 route product structure diagram
    ACLKRH682303997-75-3
Inquiry

Comments (0)